ATA907681A - Verfahren zur herstellung von neuen taurinderivaten - Google Patents

Verfahren zur herstellung von neuen taurinderivaten

Info

Publication number
ATA907681A
ATA907681A AT0907681A AT907681A ATA907681A AT A907681 A ATA907681 A AT A907681A AT 0907681 A AT0907681 A AT 0907681A AT 907681 A AT907681 A AT 907681A AT A907681 A ATA907681 A AT A907681A
Authority
AT
Austria
Prior art keywords
producing new
taurine derivatives
taurine
derivatives
producing
Prior art date
Application number
AT0907681A
Other languages
English (en)
Other versions
AT376206B (de
Original Assignee
Medica Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Pharma Co Ltd filed Critical Medica Pharma Co Ltd
Publication of ATA907681A publication Critical patent/ATA907681A/de
Application granted granted Critical
Publication of AT376206B publication Critical patent/AT376206B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
AT0907681A 1980-06-06 1981-05-22 Verfahren zur herstellung von neuen taurinderivaten AT376206B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8004261A SE434638B (sv) 1980-06-06 1980-06-06 Nya terapeutiska verdefulla taurinderivat och deras framstellning
PCT/FI1981/000037 WO1981003492A1 (en) 1980-06-06 1981-05-22 Chemical compounds,their production,and their use in drugs

Publications (2)

Publication Number Publication Date
ATA907681A true ATA907681A (de) 1984-03-15
AT376206B AT376206B (de) 1984-10-25

Family

ID=20341162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0907681A AT376206B (de) 1980-06-06 1981-05-22 Verfahren zur herstellung von neuen taurinderivaten

Country Status (26)

Country Link
US (1) US4556673A (de)
JP (1) JPS57500877A (de)
AT (1) AT376206B (de)
BE (1) BE889100A (de)
CA (1) CA1165322A (de)
CH (1) CH647505A5 (de)
CS (2) CS235088B2 (de)
DD (1) DD159427A5 (de)
DE (1) DE3152071C2 (de)
DK (1) DK155521B (de)
ES (1) ES502761A0 (de)
FI (1) FI67214C (de)
FR (1) FR2486077B1 (de)
GB (1) GB2093457B (de)
HU (1) HU184871B (de)
IE (1) IE51264B1 (de)
IL (1) IL62824A (de)
IT (1) IT8122151A0 (de)
NL (1) NL8120217A (de)
NO (1) NO155840C (de)
PL (2) PL128574B1 (de)
PT (1) PT73061B (de)
SE (1) SE434638B (de)
SU (1) SU1097198A3 (de)
WO (1) WO1981003492A1 (de)
ZA (1) ZA813387B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
AU2006200033B8 (en) * 1998-10-30 2008-09-11 Celgene Corporation Substituted phenethylsulfones and methods of reducing TNF-alpha levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US6326388B1 (en) 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US6699899B1 (en) * 1999-12-21 2004-03-02 Celgene Corporation Substituted acylhydroxamic acids and method of reducing TNFα levels
US8030343B2 (en) * 2000-06-08 2011-10-04 Celgene Corporation Pharmaceutically active isoindoline derivatives
US7491634B2 (en) * 2006-04-28 2009-02-17 Asm International N.V. Methods for forming roughened surfaces and applications thereof
WO2003000654A1 (en) * 2001-06-26 2003-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
CN114539106B (zh) * 2022-03-15 2023-05-02 梯尔希(南京)药物研发有限公司 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2184279A (en) * 1937-11-27 1939-12-26 Squibb & Sons Inc Amino-aliphatic sulphonamides and process for preparing them
AT219039B (de) * 1959-05-27 1962-01-10 Geigy Ag J R Verfahren zur Herstellung von neuen Isoindolinderivaten
GB1254414A (en) * 1969-05-08 1971-11-24 Shun-Ichi Naito Novel aminoethanesulfonylamino derivatives and their production
US4093723A (en) * 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
ZA76757B (en) * 1975-03-18 1977-01-26 Smithkline Corp New cephalosporin compounds
US4048311A (en) * 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
DE3152071T1 (de) 1983-10-20
SE434638B (sv) 1984-08-06
ES8203342A1 (es) 1982-04-01
CS235088B2 (en) 1985-04-16
ZA813387B (en) 1982-06-30
NL8120217A (de) 1982-08-02
WO1981003492A1 (en) 1981-12-10
FR2486077B1 (de) 1988-08-12
DD159427A5 (de) 1983-03-09
FI67214B (fi) 1984-10-31
IE51264B1 (en) 1986-11-26
NO155840C (no) 1987-06-10
PL128321B1 (en) 1984-01-31
SU1097198A3 (ru) 1984-06-07
FI821650L (fi) 1982-05-11
PT73061B (en) 1982-07-01
NO155840B (no) 1987-03-02
IL62824A (en) 1984-07-31
GB2093457B (en) 1984-03-21
CS235091B2 (en) 1985-04-16
US4556673A (en) 1985-12-03
HU184871B (en) 1984-10-29
SE8004261L (sv) 1981-12-07
IT8122151A0 (it) 1981-06-05
FR2486077A1 (de) 1982-01-08
DK155521B (da) 1989-04-17
FI67214C (fi) 1985-02-11
DK30082A (da) 1982-01-25
CH647505A5 (de) 1985-01-31
PT73061A (en) 1981-06-01
IL62824A0 (en) 1981-07-31
CA1165322A (en) 1984-04-10
DE3152071C2 (de) 1989-06-15
BE889100A (fr) 1981-12-04
ES502761A0 (es) 1982-04-01
IE811037L (en) 1981-12-06
GB2093457A (en) 1982-09-02
PL128574B1 (en) 1984-02-29
JPS57500877A (de) 1982-05-20
PL235510A1 (de) 1982-11-22
PL231531A1 (de) 1982-08-30
FI821650A0 (fi) 1982-05-11
AT376206B (de) 1984-10-25
NO820213L (no) 1982-01-25

Similar Documents

Publication Publication Date Title
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
ATA907681A (de) Verfahren zur herstellung von neuen taurinderivaten
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT375923B (de) Verfahren zur herstellung von neuen indolinonderivaten
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT380478B (de) Verfahren zur herstellung von neuen kondensierten as-triazin-derivaten
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
AT374807B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT373895B (de) Verfahren zur herstellung von neuen 7alpha -methoxycephalosporinderivaten
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten
AT373890B (de) Verfahren zur herstellung von neuen 1,4;3,6-dianhydro-2,5-diazido-2,5-didesoxy-hexit-derivaten
AT374482B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten
AT378195B (de) Verfahren zur herstellung von neuen ergopeptinderivaten
ATA46086A (de) Verfahren zur herstellung von neuen 2-thiacephemderivaten
ATA76188A (de) Verfahren zur herstellung von neuen mitosan-derivaten
ATA76288A (de) Verfahren zur herstellung von neuen mitosan-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee